FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/10/046717 [Registered on: 21/10/2022] Trial Registered Prospectively
Last Modified On: 16/02/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Other 
Public Title of Study   Comparison of ropivacaine and bupivacaine for spinal anaesthesia. 
Scientific Title of Study   Comparison of 0.75% hyperbaric ropivacaine versus 0.5% hyperbaric bupivacaine in spinal anaesthesia for elective surgery 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Pragati Volvoikar 
Designation  DNB Trainee 
Affiliation  Bhabha Atomic Research Centre 
Address  Department of Anaesthesiology, BARC hospital,Anushaktinagar, Mumbai.

Mumbai
MAHARASHTRA
400094
India 
Phone  9823136851  
Fax    
Email  pragati3370@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Shrividhya Chellam 
Designation  Consultant Anaesthesiology 
Affiliation  Bhabha Atomic Research Centre 
Address  Department of Anaesthesiology, BARC hospital,Anushaktinagar, Mumbai.

Mumbai (Suburban)
MAHARASHTRA
400094
India 
Phone  9521354101  
Fax    
Email  shrivic@barc.gov.in  
 
Details of Contact Person
Public Query
 
Name  Dr Pragati Volvoikar 
Designation  DNB Trainee 
Affiliation  Bhabha Atomic Research Centre 
Address  Department of Anaesthesiology, BARC hospital,Anushaktinagar, Mumbai.

Mumbai (Suburban)
MAHARASHTRA
400094
India 
Phone  9823136851  
Fax    
Email  pragati3370@gmail.com  
 
Source of Monetary or Material Support  
BARC Hospital 
 
Primary Sponsor  
Name  Bhabha Atomic Research Centre 
Address  Department of Anaesthesiology, BARC hospital,Anushaktinagar, Mumbai. 
Type of Sponsor  Other [DNB Training Central Government Hospital] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Pragati Volvoikar  BARC Hospital  2nd floor, main operation theatre, Department Of Anaesthesiology, BARC Hospital, Anushaktinagar, Mumbai.
Mumbai
MAHARASHTRA 
9823136851

pragati3370@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
BARC Hospital Medical Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: 8||Other Procedures,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  0.5 % hyperbaric Bupivacaine  Patients will be divided into two groups. Group 1 – 3ml hyperbaric 0.75% ropivacaine Group 2- 3ml hyperbaric 0.5% bupivacaine Patients will be randomly divided into two groups which will be slip in the box method. group 2 will be compared with group 1 for parameters as mentioned in details. 
Comparator Agent  0.75% hyperbaric ropivacaine  Patients will be divided into two groups. Group 1 – 3ml hyperbaric 0.75% ropivacaine Group 2- 3ml hyperbaric 0.5% bupivacaine Patients will be randomly divided into two groups which will be slip in the box method. Patients monitoring for Systolic Blood Pressure, Diastolic Blood Pressure, Mean Arterial Pressure, heart rate, SpO2 along with level of sensory and motor blockade will be assessed. Time taken for maximum sensory block along with level will be assessed by checking loss of cold sensation using ether swab.time taken for maximum motor blockade along with level will be assessed by Modified Bromage Scale. From above data time taken for achieving The total duration of spinal anaesthesia will be measured from 0 minute till 5 segment sensory regression or modified bromage 1 whichever is earlier. Any episode of hypotension or bradycardia will be noted.  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients aged 18-60 years, ASA grade I-II undergoing elective infra-umbilical surgeries, less than 2hours, under spinal anaesthesia. 
 
ExclusionCriteria 
Details  Patient refusal
Pregnancy
Allergy to local anesthetic drugs
Any other contra indications to spinal anaesthesia
 
 
Method of Generating Random Sequence   Other 
Method of Concealment   Other 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
To study duration of action of hyperbaric ropivacaine and hyperbaric bupivacaine.  24hours 
 
Secondary Outcome  
Outcome  TimePoints 
To study
1.Time taken to achieve maximum sensory blockade.
2.Time taken to achieve maximum motor blockade.
3.Intra-operative hemodynamics.
4.Time taken for 5 segment regression of sensory block.
5.Time taken for regression of motor blockade to modified Bromage 1.
6.Side effects if any
 
24hours 
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "50"
Final Enrollment numbers achieved (India)="50" 
Phase of Trial   N/A 
Date of First Enrollment (India)   27/10/2022 
Date of Study Completion (India) 07/08/2023 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   None yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

50 Patients posted for elective infra-umbilical procedures will be grouped into 2 groups, Ropivacaine(25) versus Bupivacaine(25). Spinal anaesthesia will be performed and the following  parameters will be studied.

Time taken to achieve maximum Sensory block.

Time taken to achieve Complete Motor block.

Intra-operative Hemodynamics.

Time taken for  5 segment regression of sensory block.

Time taken for  regression of Motor block to Modified Bromage 1.

Side effects.

 
Close